SISTEMA ASIA FUND MARKS SECOND EXIT WITH SALE OF NETMEDS - GADGET-INNOVATIONS

GADGET-INNOVATIONS

Updates On Latest Technology, Innovations, Apps, Softwares, Mobiles, Computing, Gadgets, Appliances, Fashion, Healthcare, Auto & Many Others......

Post Top Ad

SISTEMA ASIA FUND MARKS SECOND EXIT WITH SALE OF NETMEDS

Share This

 

The deal sees the venture capital fund reap attractive returns within three years of its investment into the e-pharmacy startup


Sistema Asia Fund today announced that it has sold its stake in Netmeds, one of India’s leading online pharmaceutical marketplace. The deal is part of the transaction in which Reliance, a Fortune 500 company and the largest private-sector corporation in India, will acquire the e-pharmacy startup.

 

Sistema Asia Fund is a venture capital fund sponsored by Sistema PJSFC, a publicly-traded diversified Russian holding company. The fund focuses on investing in technology-enabled, consumer and business-oriented startups in India and Southeast Asia - namely those with exceptional teams, global scaling potential and solid revenue streams.


Sistema Asia Fund first invested in Netmeds in 2017 and this exit will gather attractive returns for the venture capital fund as the online pharmaceutical startup grew four times its size over the past three years. The deal also marks Sistema Asia Fund’s second exit and monetisation, after selling its stake in Qwikcilver in March 2019. Sistema Asia Fund is in the process of doing a final close of its first fund this year at US$120 million.


Andrey added “Reliance’s backing of Netmeds is a strong endorsement of our investment philosophy, which is to optimise our investors' money into promising projects in India’s fast-growing technology market. We are confident that Reliance’s entry will accelerate Netmeds’ growth and help the startup establish itself as the leader in the online pharmacy sector. We want to wish Netmeds continued successful growth and realise its fullest potential with Reliance.”

 

Founded by Pradeep Dadha in 2010, Netmeds is one of India's leading e-pharmacy brand driven to revolutionise India’s healthcare sector. Currently, the startup serves over 4 million customers nationwide, enabling them to purchase medicine online, sign up for monthly pharmaceutical subscriptions, book lab tests, organise health checkups and consult verified doctors online. The company’s services saw an especially high demand during the COVID-19 pandemic, such as their delivery service which supplied medicine to patients in over 14,000 regions across India.

 

Currently, following its exit from Netmeds, Sistema Asia Fund is an investor in eight companies, including Licious (a direct-to-consumer meat and seafood brand), Rebel Foods (a multi-brand full stack online food-on-demand app), Uniphore (a conversational AI technology company), Lendingkart Technologies (an online financing company assisting SMEs with financing working capital for SMEs), HealthifyMe (a health and fitness mobile app), Seclore (an enterprise data security company) and Kissht (a consumer lending FinTech platform).




New Delhi, August 19, 2020


Youtube

Post Bottom Ad